Azurity_r_rgb

About Us:

Triptodur® (triptorelin) for extended-release injectable suspension is an FDA approved medication distributed in the US by Azurity Pharmaceuticals, Inc. Azurity is a privately held, specialty pharmaceutical company that focuses on developing innovative products that meet the needs of patients with underserved conditions. For more information regarding Triptodur® (triptorelin) for extended release injectable suspension, visit www.triptodur.com/hcp or send email inquiries to medical.information@azurity.com.

Triptodur® is manufactured by Debiopharm Research & Manufacturing SA on behalf of Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc. Triptodur® is a registered trademark of Debiopharm International SA.

Address:

8 Cabot Road, Suite 2000

Woburn, MA 01801

Email:

medical.information@azurity.com

Website:

www.triptodur.com/hcp/

Brief summary of the materials and/or video content:

Triptodur Administration Video: Watch a step-by-step video on how to administer Triptodur.

 

Click here to watch the Triptodur Administration Video: https://vimeo.com/364073964/aa6a2a8c72

Click here to watch the Triptodur Administration Video:

https://vimeo.com/364073964/aa6a2a8c72

Have questions? Please contact:

medical.information@azurity.com

Enter the MAP Spotlight Raffle